Results 141 to 150 of about 57,853 (260)

Mycoplasma Pneumoniae Encephalitis

open access: yesPediatric Neurology Briefs, 2007
The epidemiological, clinical, laboratory, and imaging findings of patients with M. pneumoniae encephalitis referred to the California Encephalitis Project are reported from the California Department of Health Services, Viral and Rickettsial Disease Laboratory, Richmond, CA, and the Centers for Disease Control and Prevention, Atlanta, GA.
openaire   +4 more sources

What is the best macrolide for atypical pneumonia? [PDF]

open access: yes, 2004
Erythromycin, clarithromycin, and azithromycin are equally effective in treating pneumonia caused by Mycoplasma pneumoniae or Chlamydophila (formerly Chlamydia) pneumoniae (strength of recommendation [SOR]: B, small head-to-head trials). Macrolide choice
Morton, Jacquelyn R., Neher, Jon O.
core  

Evidence for symmetric chromosomal inversions around the replication origin in bacteria. [PDF]

open access: yes, 2000
BackgroundWhole-genome comparisons can provide great insight into many aspects of biology. Until recently, however, comparisons were mainly possible only between distantly related species.
Eisen, JA   +3 more
core   +1 more source

Clinical characteristics and risk factors of pulmonary embolism with Mycoplasma pneumoniae pneumonia in children

open access: yesScientific Reports
Pulmonary embolism is a rare but serious complication in Mycoplasma pneumoniae pneumonia patients, leading to serious sequelae and even death. We aim to retrospectively analyze the clinical features of Mycoplasma pneumoniae pneumonia with pulmonary ...
Xue Zhang   +6 more
doaj   +1 more source

Phase-shifting of the transmissibility of macrolide-sensitive and resistant Mycoplasma pneumoniae epidemics in Hong Kong, from 2015 to 2018

open access: yesInternational Journal of Infectious Diseases, 2019
Mycoplasma pneumoniae is a threat to public health. This pathogen caused an epidemic in Hong Kong during the years 2015–2018. The reproduction number during the initial epidemic was estimated to be 1.7 for macrolide-resistant M. pneumoniae (MRMP) and 1.4
Shi Zhao   +3 more
doaj  

Home - About - Disclaimer - Privacy